Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

2 BIO Stocks in the News: (NASDAQ: GALE), (NYSE: NAVB)

Accesswire March 19, 2013

Galena Biopharma Acquires Abstral(R) (fentanyl) Sublingual Tablets in U.S., a Novel, Best-in-Class Treatment Approved for Breakthrough Cancer Pain

Troy Schwensen March 18, 2013

Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM)

Troy Schwensen March 14, 2013

Galena Biopharma Reports Year-End 2012 Financial Results

Troy Schwensen March 12, 2013

Stocks Reports For: (NASDAQ: GALE), (NYSE: CIM)

Accesswire March 12, 2013

Frost & Sullivan Applauds Galena Biopharma for its Breakthrough Breast Cancer Vaccine, NeuVax(TM)

PR Newswire March 12, 2013

Galena Biopharma to Present at the 25th Annual ROTH Conference

Troy Schwensen March 11, 2013

Galena Biopharma to Present at the 7th Annual Bio-Europe International Partnering Conference

Troy Schwensen March 4, 2013

Free Research Reports on CBLI, GALE, GLUU and SAN Issued by the Bedford Report

Marketwired February 5, 2013

Galena Biopharma to Present at the 15th Annual Bio CEO & Investor Conference

Troy Schwensen February 5, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Marketwired February 4, 2013

Free Research Reports on GALE, LDK, MCP and WIN Issued by the Bedford Report

Marketwired January 22, 2013

Key to Success, How to Profit: CLSN, GALE, KERX and JAZZ

Marketwired January 11, 2013

Biotech Industry Expected to Experience More M&A Activity in 2013

Marketwired January 10, 2013

Perfect Trade Setups, How to Play CLSN, GALE, KERX and JAZZ

Marketwired January 9, 2013

Our Pros Knew RIG, GALE, GNC and ONXX Would Be Top Gainers on Friday

Marketwired January 7, 2013